These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
333 related items for PubMed ID: 4035666
21. Digestible energy and efficiency of feed utilization in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Seefeld MD, Peterson RE. Toxicol Appl Pharmacol; 1984 Jun 30; 74(2):214-22. PubMed ID: 6740672 [Abstract] [Full Text] [Related]
22. Relationship of the wasting syndrome to lethality in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Christian BJ, Inhorn SL, Peterson RE. Toxicol Appl Pharmacol; 1986 Feb 30; 82(2):239-55. PubMed ID: 3945951 [Abstract] [Full Text] [Related]
23. Comparative teratological studies on TCDD, endrin and lindane in C57BL/6J and DBA/2J mice. Hassoun EA, Stohs SJ. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1996 Mar 30; 113(3):393-8. PubMed ID: 8697196 [Abstract] [Full Text] [Related]
24. Characteristics of 2,3,7,8-tetrachlorodibenzo-p-dioxin induced endotoxin hypersensitivity: association with hepatotoxicity. Rosenthal GJ, Lebetkin E, Thigpen JE, Wilson R, Tucker AN, Luster MI. Toxicology; 1989 Jun 16; 56(3):239-51. PubMed ID: 2472021 [Abstract] [Full Text] [Related]
25. Comparative toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in four (sub)strains of adult male rats. Walden R, Schiller CM. Toxicol Appl Pharmacol; 1985 Mar 15; 77(3):490-5. PubMed ID: 3975916 [Abstract] [Full Text] [Related]
26. 2,3,7,8-Tetrachlorodibenzo-p-dioxin pretreatment of female mice altered tissue distribution but not hepatic metabolism of a subsequent dose. Curtis LR, Kerkvliet NI, Baecher-Steppan L, Carpenter HM. Fundam Appl Toxicol; 1990 Apr 15; 14(3):523-31. PubMed ID: 2340981 [Abstract] [Full Text] [Related]
27. Toxicity and evidence for metabolic alterations in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated guinea pigs fed by total parenteral nutrition. Huang Lu CJ, Baggs RB, Redmond D, Henry EC, Schecter A, Gasiewicz TA. Toxicol Appl Pharmacol; 1986 Jul 15; 84(3):439-53. PubMed ID: 3088772 [Abstract] [Full Text] [Related]
28. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced change in intestinal function and pathology: evidence for the involvement of arylhydrocarbon receptor-mediated alteration of glucose transportation. Ishida T, Kan-o S, Mutoh J, Takeda S, Ishii Y, Hashiguchi I, Akamine A, Yamada H. Toxicol Appl Pharmacol; 2005 May 15; 205(1):89-97. PubMed ID: 15885268 [Abstract] [Full Text] [Related]
29. Intermediary metabolism of the mature rat following 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment. Christian BJ, Menahan LA, Peterson RE. Toxicol Appl Pharmacol; 1986 Apr 15; 83(2):360-78. PubMed ID: 3961820 [Abstract] [Full Text] [Related]
30. Dose response and time course of alterations in tryptophan metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the most TCDD-susceptible and the most TCDD-resistant rat strain: relationship with TCDD lethality. Unkila M, Pohjanvirta R, MacDonald E, Tuomisto JT, Tuomisto J. Toxicol Appl Pharmacol; 1994 Oct 15; 128(2):280-92. PubMed ID: 7940543 [Abstract] [Full Text] [Related]
31. Influence of the Ah locus on the humoral immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: evidence for Ah-receptor-dependent and Ah-receptor-independent mechanisms of immunosuppression. Kerkvliet NI, Steppan LB, Brauner JA, Deyo JA, Henderson MC, Tomar RS, Buhler DR. Toxicol Appl Pharmacol; 1990 Aug 15; 105(1):26-36. PubMed ID: 2168100 [Abstract] [Full Text] [Related]
32. Characterization of the wasting syndrome in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Seefeld MD, Corbett SW, Keesey RE, Peterson RE. Toxicol Appl Pharmacol; 1984 Apr 15; 73(2):311-22. PubMed ID: 6710531 [Abstract] [Full Text] [Related]
33. Modulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in F344 rats by di(2-ethylhexyl)phthalate. Tomaszewski KE, Montgomery CA, Melnick RL. Chem Biol Interact; 1988 Apr 15; 65(3):205-22. PubMed ID: 3378278 [Abstract] [Full Text] [Related]
34. Species differences in estrogen receptors and in the response to 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure. Hruska RE, Olson JR. Toxicol Lett; 1989 Sep 15; 48(3):289-99. PubMed ID: 2781598 [Abstract] [Full Text] [Related]
35. Corticosterone decreases toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in hypophysectomized rats. Gorski JR, Lebofsky M, Rozman K. J Toxicol Environ Health; 1988 Sep 15; 25(3):349-60. PubMed ID: 3184202 [Abstract] [Full Text] [Related]
36. Dioxin-induced retardation of development through a reduction in the expression of pituitary hormones and possible involvement of an aryl hydrocarbon receptor in this defect: a comparative study using two strains of mice with different sensitivities to dioxin. Takeda T, Taura J, Hattori Y, Ishii Y, Yamada H. Toxicol Appl Pharmacol; 2014 Aug 01; 278(3):220-9. PubMed ID: 24793433 [Abstract] [Full Text] [Related]
38. Hepatotoxic doses of dioxin do not damage mouse bone marrow chromosomes. Meyne J, Allison DC, Bose K, Jordan SW, Ridolpho PF, Smith J. Mutat Res; 1985 Jul 01; 157(1):63-9. PubMed ID: 4010698 [Abstract] [Full Text] [Related]
40. Metabolomic analysis of liver and skeletal muscle tissues in C57BL/6J and DBA/2J mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Lin S, Yang Z, Liu H, Cai Z. Mol Biosyst; 2011 Jun 01; 7(6):1956-65. PubMed ID: 21465055 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]